AHL Partners’s Cantel Medical Corporation CMD Stock Holding History

AHL Partners’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$1.31M	Buy	12,786 +2,185	+21%	+$218K	0.02%	824
2017 Q3	$999K	Sell	10,601 -6,038	-36%	-$477K	0.02%	883
2017 Q2	$1.3M	Sell	16,639 -1,203	-7%	-$90.4K	0.03%	711
2017 Q1	$1.43M	Buy	17,842 +12,243	+219%	+$973K	0.03%	701
2016 Q4	$441K	Sell	5,599 -6,067	-52%	-$471K	0.01%	892
2016 Q3	$910K	Sell	11,666 -4,138	-26%	-$300K	0.03%	629
2016 Q2	$1.09M	Buy	15,804 +6,731	+74%	+$464K	0.06%	413
2016 Q1	$647K	Buy	+9,073	New	+$570K	0.04%	509

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

AHL Partners's CMD Position: Q4 2017 in Review

AHL Partners increased its Cantel Medical Corporation (CMD) stake by 21% in Q4 2017, buying an estimated $218K and bringing the position to 12,786 shares worth $1.31M. The position accounts for 0.02% of the portfolio, ranked #824.

AHL Partners first reported a position in CMD in Q1 2016 and has held it in 8 quarters since. The position peaked at $1.43M in Q1 2017. 245 funds tracked by Wall St. Rank hold CMD as of Q4 2017.

AHL Partners held 12,786 shares of Cantel Medical Corporation worth $1.31M as of Q4 2017.
AHL Partners bought 2,185 Cantel Medical Corporation shares in Q4 2017, an estimated $218K.
Cantel Medical Corporation made up 0.02% of AHL Partners's portfolio in Q4 2017, its #824 holding.
AHL Partners first reported a position in Cantel Medical Corporation in Q1 2016 and has held it in 8 quarters since.
AHL Partners's Cantel Medical Corporation position peaked at $1.43M in Q1 2017.
245 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.